NIOX Group Plc (CSSPF)
USD 0.65
(-13.33%)
USD 0.65
(-13.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 9.8 Million USD | -51.18% |
| 2022 | 20.07 Million USD | -24.23% |
| 2021 | 26.49 Million USD | -47.61% |
| 2020 | 50.57 Million USD | -76.43% |
| 2019 | 214.6 Million USD | -7.16% |
| 2018 | 231.15 Million GBP | -3.78% |
| 2017 | 240.24 Million GBP | 264.1% |
| 2016 | 65.98 Million GBP | -43.69% |
| 2015 | 117.17 Million GBP | 1107.99% |
| 2014 | 9.7 Million GBP | 21.45% |
| 2013 | 7.98 Million GBP | 59.14% |
| 2012 | 5.01 Million GBP | 0.95% |
| 2011 | 4.97 Million GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 7.2 Million USD | 0.0% |
| 2023 FY | 9.8 Million USD | -51.18% |
| 2023 Q4 | 9.8 Million USD | 4.34% |
| 2023 Q3 | 9.39 Million GBP | -50.33% |
| 2023 Q2 | 18.91 Million USD | 2.89% |
| 2023 Q1 | 18.38 Million GBP | -8.44% |
| 2022 Q3 | 18.53 Million GBP | -19.84% |
| 2022 Q4 | 20.07 Million USD | 8.3% |
| 2022 FY | 20.07 Million USD | -24.23% |
| 2022 Q1 | 24.95 Million GBP | -5.8% |
| 2022 Q2 | 23.12 Million GBP | -7.35% |
| 2021 Q3 | 26.41 Million GBP | -21.32% |
| 2021 Q1 | 33.49 Million GBP | -33.77% |
| 2021 Q2 | 33.56 Million GBP | 0.21% |
| 2021 Q4 | 26.49 Million GBP | 0.32% |
| 2021 FY | 26.49 Million USD | -47.61% |
| 2020 Q2 | 59.67 Million GBP | -0.62% |
| 2020 FY | 50.57 Million USD | -76.43% |
| 2020 Q4 | 50.57 Million GBP | 5.94% |
| 2020 Q3 | 47.74 Million GBP | -20.0% |
| 2020 Q1 | 60.05 Million GBP | -72.02% |
| 2019 Q3 | 199.19 Million GBP | -26.59% |
| 2019 Q4 | 214.6 Million GBP | 7.74% |
| 2019 Q2 | 271.33 Million GBP | -2.28% |
| 2019 Q1 | 277.67 Million GBP | 52.99% |
| 2019 FY | 214.6 Million USD | -7.16% |
| 2018 Q1 | 38.86 Million GBP | -78.12% |
| 2018 FY | 231.15 Million GBP | -3.78% |
| 2018 Q4 | 181.5 Million GBP | 11.95% |
| 2018 Q3 | 162.12 Million GBP | -11.31% |
| 2018 Q2 | 182.8 Million GBP | 370.34% |
| 2017 Q2 | 128.3 Million GBP | 231.38% |
| 2017 Q1 | 38.71 Million GBP | -27.5% |
| 2017 FY | 240.24 Million GBP | 264.1% |
| 2017 Q4 | 177.6 Million GBP | 330.38% |
| 2017 Q3 | 41.26 Million GBP | -67.84% |
| 2016 Q4 | 53.4 Million GBP | 91.59% |
| 2016 Q1 | 33.41 Million GBP | -57.97% |
| 2016 FY | 65.98 Million GBP | -43.69% |
| 2016 Q3 | 27.87 Million GBP | -49.96% |
| 2016 Q2 | 55.7 Million GBP | 66.69% |
| 2015 Q1 | 77.86 Million GBP | 702.72% |
| 2015 FY | 117.17 Million GBP | 1107.99% |
| 2015 Q4 | 79.5 Million GBP | 8.77% |
| 2015 Q3 | 73.08 Million GBP | -21.78% |
| 2015 Q2 | 93.43 Million GBP | 20.0% |
| 2014 Q4 | 9.7 Million GBP | -38.35% |
| 2014 Q1 | 6.72 Million GBP | -15.86% |
| 2014 Q2 | 4.03 Million GBP | -40.0% |
| 2014 Q3 | 15.73 Million GBP | 290.26% |
| 2014 FY | 9.7 Million GBP | 21.45% |
| 2013 Q3 | 12.93 Million GBP | 0.0% |
| 2013 Q4 | 7.98 Million GBP | -38.23% |
| 2013 Q1 | - GBP | 0.0% |
| 2013 FY | 7.98 Million GBP | 59.14% |
| 2012 FY | 5.01 Million GBP | 0.95% |
| 2011 FY | 4.97 Million GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BioElectronics Corporation | 16.62 Million USD | 41.032% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -1346.557% |
| Polarean Imaging plc | 2.58 Million USD | -279.847% |
| Avitar, Inc. | 11.59 Million USD | 15.452% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -1446.073% |
| AVITA Medical, Inc. | 19.86 Million USD | 50.657% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -362.8% |
| Össur hf. | 688.8 Million USD | 98.577% |
| Zecotek Photonics Inc. | 5.86 Million USD | -67.026% |
| QHSLab, Inc. | 2.05 Million USD | -376.513% |
| Wellstar International, Inc. | 55.99 Million USD | 82.493% |
| Össur hf. | 688.8 Million USD | 98.577% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 39.044% |
| Escalon Medical Corp. | 2.94 Million USD | -232.461% |
| Aurora Spine Corporation | 6.65 Million USD | -47.322% |
| BrainsWay Ltd. | 15.31 Million USD | 35.993% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -63.025% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 78.618% |
| Vivos Inc. | 245 Thousand USD | -3900.792% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.606% |
| Kelyniam Global, Inc. | 1.01 Million USD | -867.693% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -3456.459% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -300.117% |
| Nanomix Corporation | 14.81 Million USD | 33.836% |
| Theraclion SA | 13.01 Million EUR | 24.695% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -91.29% |
| Positron Corporation | 2.02 Million USD | -383.816% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -170.689% |
| Lombard Medical, Inc. | 53.79 Million USD | 81.778% |
| ALR Technologies Inc. | 24.5 Million USD | 60.0% |
| Stratec SE | 271.97 Million USD | 96.396% |
| Vycor Medical, Inc. | 4.31 Million USD | -127.017% |
| Heart Tronics, Inc. | 1.09 Million USD | -795.341% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -315.557% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -78.983% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 85.056% |
| VMS Rehab Systems, Inc. | 201.36 USD | -4867847.954% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -79.034% |
| Ingen Technologies, Inc. | 5.7 Million USD | -71.679% |
| Odyssey Group International, Inc. | 6.61 Million USD | -48.253% |
| United American Healthcare Corporation | 119 Thousand USD | -8137.059% |
| ECGI Holdings, Inc. | 11.94 Million USD | 17.908% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -640.349% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -577.719% |
| Urologix, Inc. | 12.64 Million USD | 22.476% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -81.653% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -15.557% |
| SS Innovations International, Inc. | 11.18 Million USD | 12.333% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -1765.691% |
| Smith & Nephew plc | 4.76 Billion USD | 99.794% |
| Fuse Medical, Inc. | 15.11 Million USD | 35.129% |
| Broncus Holding Corporation | 10.43 Million USD | 6.04% |
| Brain Scientific Inc. | 7.42 Million USD | -31.99% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 71.003% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -1134.395% |